
Home - Reconcile® (fluoxetine hydrochloride)
Reconcile is an FDA-approved medication for the treatment of separation anxiety in dogs in conjunction with behavior modification training. Reconcile is a once-a-day flavored, chewable …
Product Details - Reconcile® (fluoxetine hydrochloride)
Please consult your veterinarian for an official diagnosis of canine separation anxiety and to learn more about Reconcile. Click here to read the complete terms and conditions regarding use of …
FAQ - Reconcile® (fluoxetine hydrochloride)
Reconcile (fluoxetine hydrochloride) is approved by the FDA for the treatment of separation anxiety in dogs in conjunction with a behavior modification plan. Prescribed by your …
BOND Training Information - Reconcile® (fluoxetine hydrochloride)
The veteran of calm, Reconcile ® (fluoxetine hydrochloride) is proven successful in the management of separation anxiety in dogs when administered in conjunction with the BOND …
RECONCILE chewable tablets are contraindicated for use in dogs with epilepsy or a history of seizures. RECONCILE chewable tablets should not be given concomitantly with drugs that …
RECONCILE chewable tablets should not be given in combination with a monoamine oxidase inhibitor (MAOI) [e.g., selegiline hydrochloride (L-deprenyl) or amitraz], or within a minimum of …
Behavior Bits - Reconcile® (fluoxetine hydrochloride)
Welcome to Behavior Bits! Your educational resource for behavior-related pet training tips. In this section of the web site, you will find helpful and easy-to-implement behavior training …
FDA approved Reconcile® (fluoxetine hydrochloride) is a chewable tablet used to treat separation anxiety in dogs in conjunction with behavior modification training like the BOND program.
RECONCILE chewable tablets compared to dogs that received the control tablet. At the end of the study, 73% of dogs treated with RECONCILE chewable tablets showed significant im-provement
One of 112 dogs in the control group and three of 117 dogs that received RECONCILE chewable tablets experienced the serious adverse reaction of seizures in this study. One of the three …